Kardigan is a pioneering heart health company dedicated to making cardiovascular disease preventable and curable, aiming to eliminate it as the leading cause of death globally. The company is on a mission to develop multiple targeted treatments that provide patients with the cures they deserve. Founded by industry leaders who previously led MyoKardia, Kardigan boasts a cutting-edge research platform and a robust pipeline of late-stage candidates. The team is driven by a commitment to patient-centered values, authenticity, continuous learning, teamwork, and innovation, all aimed at improving the lives of patients with cardiovascular diseases.